학술논문

Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention
Document Type
Academic Journal
Source
American Heart Journal. Oct, 2018, Vol. 204, 34
Subject
Cardiology
Mortality
Medical research
Medicine, Experimental
Transluminal angioplasty
Blood clot
Thrombosis
Health
Language
English
ISSN
0002-8703
Abstract
Byline: Sarah Hugelshofer, MD (a), Marco Roffi, MD (b), Fabienne Witassek, MS (c), Franz R. Eberli, MD (d), Thomas Pilgrim, MD (e), Giovanni Pedrazzini, MD (f), Hans Rickli, MD (g), Dragana Radovanovic, MD (c), Paul Erne, MD (h), Sophie Degrauwe, MD (b), Olivier Muller, MD PhD (a), Pier Giorgio Masci, MD PhD (a), Stephan Windecker, MD (e), Juan F. Iglesias, MD [JuanFernando.Iglesias@hcuge.ch] (b,*) Background The benefits of manual thrombus aspiration (TA) during primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) remain uncertain. We assessed the influence of total ischemic time (TIT) on clinical outcomes among STEMI patients undergoing manual TA during pPCI. Methods and results We conducted a retrospective study of patients enrolled in the Acute Myocardial Infarction in Switzerland Plus registry. STEMI patients undergoing pPCI with (TA group) or without (PCI-alone group) manual TA were stratified based on short (6 hours) TIT. The primary endpoint was in-hospital all-cause mortality. The secondary endpoint was in-hospital major adverse cardiac events (MACE), a composite of all-cause death, myocardial reinfarction and stroke. Between 2008 and 2014, 4'154 patients (TA 48%) were included. Risk-adjusted in-hospital all-cause mortality was not different between TA and PCI-alone groups (OR 1.29; 95%CI 0.83-1.98; p=0.26), whereas there was significantly increased risk of MACE (OR 1.52; 95%CI 1.05-2.19; p=0.03) in patients treated with manual TA compared with PCI-alone. There was no significant difference between manual TA and PCI-alone with respect to risk-adjusted all-cause mortality according to TIT groups, but risk-adjusted MACE rates were significantly higher in the group of patients with long TIT treated with manual TA compared with PCI-alone (OR 2.42; 95%CI 1.16-5.04; p=0.02). Conclusion In a large registry of STEMI patients, manual TA was not associated with lower risk-adjusted in-hospital all-cause mortality compared with PCI-alone regardless of TIT but was associated with significantly greater risk of MACE. In patients with prolonged TIT, manual TA was associated with higher risk-adjusted MACE rates compared with PCI-alone. Author Affiliation: (a) Department of Cardiology, Lausanne University Hospital, Switzerland (b) Division of Cardiology, University Hospital, Geneva, Switzerland (c) AMIS Plus Data Center, University of Zurich, Switzerland (d) Department of Cardiology, Triemli Hospital, Zurich, Switzerland (e) Department of Cardiology, Bern University Hospital, Switzerland (f) Department of Cardiology, Cardiocentro Ticino, Lugano, Switzerland (g) Division of Cardiology, Kantonsspital St. Gallen, Switzerland (h) Faculty of Biomedical Sciences, Universita della Svizzera Italiana, Switzerland * Reprint requests: Juan F. Iglesias, MD, Division of Cardiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland. Article History: Received 7 November 2017; Accepted 30 May 2018 (footnote) Disclosures: The authors have no conflicts of interest to declare.